Viaskin milk patch vs placebo
Endoscopic improvement (continuous) · active EoE pediatric patients
1 finding from 1 review
- no estimate extracted1 study · 20 participantsLow
Viaskin milk patch showed no clear difference in withdrawals due to adverse events at 44 weeks compared with placebo (low certainty).
It is very uncertain whether leukotriene receptor antagonist changes clinical improvement at 26 weeks (dichotomous) compared with placebo (very low certainty).